Pasithea Therapeutics (KTTA) Earnings Date & Reports
Pasithea Therapeutics Corp is a biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
KTTA is expected to report earnings to fall 79.75% to -15 cents per share on September 02
Q2'26
Est.
$-0.16
Q4'25
Missed
by $0.61
Q1'23
Est.
$-0.17
Q4'22
Est.
$-0.18
Q3'22
Missed
by $0.03
The last earnings report on March 30 showed earnings per share of -79 cents, missing the estimate of -18 cents. With 196.34K shares outstanding, the current market capitalization sits at 16.71M.